[{"id":"16a08196-e3fa-48dc-968e-2853322717f1","acronym":"","url":"https://clinicaltrials.gov/study/NCT04756934","created_at":"2021-02-16T12:53:57.352Z","updated_at":"2024-07-02T16:36:34.534Z","phase":"Phase 1","brief_title":"A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma","source_id_and_acronym":"NCT04756934","lead_sponsor":"Taizhou HoudeAoke Biomedical Co., Ltd.","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Puyouheng (pucotenlimab) • LP002"],"overall_status":"Recruiting","enrollment":" Enrollment 63","initiation":"Initiation: 08/20/2020","start_date":" 08/20/2020","primary_txt":" Primary completion: 08/20/2021","primary_completion_date":" 08/20/2021","study_txt":" Completion: 08/20/2022","study_completion_date":" 08/20/2022","last_update_posted":"2021-02-16"},{"id":"3c4e377b-7ec9-4f73-ac54-74b124fd8d1b","acronym":"","url":"https://clinicaltrials.gov/study/NCT04755543","created_at":"2021-02-16T12:53:42.450Z","updated_at":"2024-07-02T16:36:34.574Z","phase":"Phase 1","brief_title":"A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms","source_id_and_acronym":"NCT04755543","lead_sponsor":"Taizhou HoudeAoke Biomedical Co., Ltd.","biomarkers":" PD-L1","pipe":" | ","alterations":" PD-L1 expression","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • 5-fluorouracil • LP002"],"overall_status":"Recruiting","enrollment":" Enrollment 94","initiation":"Initiation: 06/17/2019","start_date":" 06/17/2019","primary_txt":" Primary completion: 06/30/2021","primary_completion_date":" 06/30/2021","study_txt":" Completion: 06/30/2022","study_completion_date":" 06/30/2022","last_update_posted":"2021-02-16"}]